8-K: MIRA Pharmaceuticals Changes Accounting Firms, Appoints Salberg & Company

MIRA Pharmaceuticals has announced the resignation of Cherry Bekaert LLP as its independent auditor and the appointment of Salberg & Company P.A. as its new auditor.

Summary

• MIRA Pharmaceuticals has changed its independent registered public accounting firm.
• Cherry Bekaert LLP resigned as the company's auditor on December 16, 2024.
• The resignation was not due to any disagreements on accounting principles or practices.
• Cherry Bekaert did identify material weaknesses in the company's internal control over financial reporting for 2022 and 2023.
• Salberg & Company P.A. was engaged as the new independent auditor on December 18, 2024.
• The company did not consult with Salberg on any accounting or auditing matters prior to their engagement.
• Cherry Bekaert confirmed their agreement with the statements made by MIRA Pharmaceuticals in the Form 8-K filing.

Sentiment

Score: 4

Explanation: The change in auditors itself is neutral, but the material weaknesses in internal controls and the going concern paragraph in the previous auditor's report are concerning, leading to a lower sentiment score.

Positives

• The change in auditors was not due to any disagreements on accounting principles or practices.
• Cherry Bekaert confirmed their agreement with the statements made by MIRA Pharmaceuticals in the Form 8-K filing.

Negatives

• Cherry Bekaert identified material weaknesses in the company's internal control over financial reporting for 2022 and 2023.
• Cherry Bekaert's reports included an explanatory paragraph regarding the company's ability to continue as a going concern.

Risks

• The identified material weaknesses in internal control over financial reporting could pose a risk to the accuracy of future financial statements.
• The going concern paragraph in the previous auditor's report indicates potential financial instability.

Industry Context

Changes in auditors are not uncommon, but the reasons for the change and any prior issues raised by the previous auditor are important to consider. The appointment of a new auditor is a standard process for public companies.

Comparison to Industry Standards

• The change of auditors is a common occurrence in the industry, and many companies switch auditors periodically for various reasons.
• The identification of material weaknesses in internal controls is not uncommon, but it is important for companies to address these issues promptly.
• The going concern paragraph in the auditor's report is a serious matter and indicates that the company's financial stability is in question. This is not a standard situation and should be monitored closely.

Stakeholder Impact

• Shareholders may be concerned about the material weaknesses in internal control and the going concern paragraph.
• Creditors may be more cautious about lending to the company due to the going concern issue.

Next Steps

• MIRA Pharmaceuticals will work with Salberg & Company P.A. for the fiscal year ending December 31, 2024.
• The company will need to address the material weaknesses in internal control over financial reporting.

Key Dates

Keywords

auditor, accounting firm, financial reporting, internal control, MIRA Pharmaceuticals, Cherry Bekaert, Salberg & Company